PBSV OTC
Pharma-Bio Serv, Inc.
1W: +13.6%
1M: -7.4%
3M: -12.3%
YTD: -4.5%
1Y: -25.4%
3Y: -40.2%
5Y: -12.6%
$0.50
+0.05 (+11.11%)
Weekly Expected Move ±24.4%
$0
$0
$0
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Cash Flow Trends
Operating Cash Flow
-$215K
+62.1% ▲
Capital Expenditures
$7K
+95.8% ▲
5Y CAGR: -34.6%
Free Cash Flow
-$222K
+69.5% ▲
Dividends Paid
$2M
+0.1% ▲
Buybacks
$31K
-179.2% ▼
Net Change in Cash
-$3M
+7.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$2M | $1M | $1M | -$778K | -$100K |
| Depreciation & Amort. | $73K | $51K | $194K | $181K | $229K |
| Stock-Based Comp. | $56K | $72K | $45K | $48K | $35K |
| Change in Working Capital | -$518K | -$537K | $661K | $228K | -$341K |
| Other Non-Cash Items | $3M | $637K | -$320K | -$246K | -$38K |
| Operating Cash Flow | $805K | $592K | $2M | -$567K | -$215K |
| — Investing Activities — | |||||
| Capital Expenditures | -$11K | -$19K | -$7K | $0 | -$7K |
| Acquisitions (Net) | $58K | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | -$1M |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $1M | -$19M | -$4M | -$1M | $0 |
| Investing Cash Flow | $1M | -$19K | -$4M | -$1M | -$1M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | -$26K | -$82K | -$34K | -$11K | -$31K |
| Dividends Paid | -$2M | -$3M | -$2M | -$2M | -$2M |
| Other Financing | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$2M | -$4M | -$2M | -$2M | -$2M |
| Net Change in Cash | $330K | -$3M | -$4M | -$4M | -$3M |
| Cash End of Period | $17M | $14M | $10M | $7M | $3M |
| Free Cash Flow | $794K | $573K | $2M | -$726K | -$222K |